This article is authored by Deepak Kapur, chairman, Rotary International India’s National PolioPlus Committee (RI-INPPC).

TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox TNX-801 protects ...

India’s immunisation journey began over two centuries ago when the country’s first smallpox vaccine was administered in ...

Tonix Pharmaceuticals (TNXP) presented data in an oral presentation at the World Vaccine Congress Washington 2025, held April 21-24, 2025, in ...

Davis replied that “we may focus on pro- tests and demonstrations too much. The South.

Britain is mounting a major pre-emptive strike against smallpox attack by germ war terrorists. Up to 60million doses of the vaccine are being stockpiled, enough to treat the entire population.

The MVA-BN vaccine showed an overall effectiveness of 57.8% (95% CI, 11.8-83.0) in reducing mpox cases at 14 days or longer after the first dose; however, the effectiveness was lower in people ...

The freeze-dried formulation provides flexibility with regard to storage and shelf life. The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox ...

Most people in the U.S. have received vaccines to protect against infectious diseases. A vaccine against smallpox led to the ...

Tonix Pharmaceuticals presented positive preclinical data for TNX-801, a single-dose vaccine against mpox and smallpox, at a recent conference. Tonix Pharmaceuticals has presented encouraging ...

even at high doses “TNX-801 shows promise as a potential mpox and smallpox vaccine by providing protective immunity to animals with a single-dose,” said Seth Lederman, M.D., Chief Executive ...